98 related articles for article (PubMed ID: 2862629)
1. [Medullary cancer of the thyroid in type IIB multiple endocrine neoplasia. Uptake of meta-iodo-benzylguanidine labeled with iodine 131].
Chamouard P; Jouin H; Varra A; Weill JP; Constantinesco A
Presse Med; 1985 Jun; 14(25):1387. PubMed ID: 2862629
[No Abstract] [Full Text] [Related]
2. [Detection by scintigraphy with meta-iodobenzylguanidine of a subclinical tumoral thyroid nodule in Sipple's syndrome].
Gallet M; Penet D; Berthet C; Kepenekian G; Fleury M; Lestaevel M
Presse Med; 1986 Jul 5-12; 15(27):1282. PubMed ID: 2876419
[No Abstract] [Full Text] [Related]
3. [Localization of medullary cancer of the thyroid gland by scintigraphy using meta-iodo-benzylguanidine].
Getin F; Rohmer V; Saint Andre JP; Jallet P; Bigorgne JC
Presse Med; 1985 Mar; 14(10):597. PubMed ID: 3157942
[No Abstract] [Full Text] [Related]
4. [Medullary thyroid cancer may take up meta-iodobenzylguanidine].
Krempf M; Chatal JF; Charbonnel B
Presse Med; 1985 Sep; 14(29):1560-1. PubMed ID: 2932697
[No Abstract] [Full Text] [Related]
5. Imaging of medullary thyroid cancer with 131I-MIBG.
Endo K; Shiomi K; Kasagi K; Konishi J; Torizuka K; Nakao K; Tanimura H
Lancet; 1984 Jul; 2(8396):233. PubMed ID: 6146795
[No Abstract] [Full Text] [Related]
6. Medullary thyroid carcinoma: localization of a mediastinal metastasis with I-131 MIBG.
Laflamme L; Taillefer R; Duranceau A; Verdy M; Schürch W
Clin Nucl Med; 1988 Aug; 13(8):577-9. PubMed ID: 2901928
[TBL] [Abstract][Full Text] [Related]
7. Imaging of metastatic medullary carcinoma of the thyroid with 131I-meta-iodobenzyl guanidine.
Poston GJ; Thomas AM; Macdonald DW; Karvounaris D; Henderson BL; George P; Lynn JA; Lavender JP
Nucl Med Commun; 1986 Apr; 7(4):215-21. PubMed ID: 2873544
[TBL] [Abstract][Full Text] [Related]
8. Iodine-131 MIBG uptake in metastatic medullary carcinoma of the thyroid. A patient treated with somatostatin.
Keeling CA; Basso LV
Clin Nucl Med; 1988 Apr; 13(4):260-3. PubMed ID: 2897264
[TBL] [Abstract][Full Text] [Related]
9. [I-131-meta-iodobenzylguanidine and multiple endocrine adenomatosis type II].
Simó R; Mesa J
Med Clin (Barc); 1987 Dec; 89(20):888. PubMed ID: 2896282
[No Abstract] [Full Text] [Related]
10. Imaging of medullary thyroid carcinoma and hyperfunctioning adrenal medulla using iodine-131 metaiodobenzylguanidine.
Ansari AN; Siegel ME; DeQuattro V; Gazarian LH
J Nucl Med; 1986 Dec; 27(12):1858-60. PubMed ID: 2878066
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic and therapeutic potential of new radiopharmaceutical agents in medullary thyroid carcinoma.
Troncone L; Rufini V; De Rosa G; Testa A
Henry Ford Hosp Med J; 1989; 37(3-4):178-84. PubMed ID: 2576959
[TBL] [Abstract][Full Text] [Related]
12. Pentavalent technetium-99m (V)-DMSA uptake in a pheochromocytoma in a patient with Sipple's syndrome.
Adams BK; Fataar A; Byrne MJ; Levitt NS; Matley PJ
J Nucl Med; 1990 Jan; 31(1):106-8. PubMed ID: 1967305
[TBL] [Abstract][Full Text] [Related]
13. Thyroid uptake of MIBG in Sipple's syndrome.
Perdrisot R; Rohmer V; Lejeune JJ; Bigorgne JC; Jallet P
Eur J Nucl Med; 1988; 14(1):37-8. PubMed ID: 2898364
[TBL] [Abstract][Full Text] [Related]
14. Screening for pheochromocytoma in the MEN 2 syndrome.
Kotzerke J; Stibane C; Dralle H; Wiese H; Burchert W
Henry Ford Hosp Med J; 1989; 37(3-4):129-31. PubMed ID: 2576945
[TBL] [Abstract][Full Text] [Related]
15. Pitfall of Sipple's syndrome diagnosis by 131I-metaiodobenzylguanidine (MIBG).
Talbot JN; Coutris G; Moulonguet M; Hoang C; Perniceni T; Milhaud G
J Nucl Med Allied Sci; 1987; 31(4):337-40. PubMed ID: 2895168
[No Abstract] [Full Text] [Related]
16. Sipple's syndrome with liver tumors examined by iodine-131 MIBG and technetium-99m(V)-DMSA.
Ohta H; Endo K; Fujita T; Koizumi M; Konishi J; Maki A; Mori K; Ozawa K; Inoue G; Nakano Y
J Nucl Med; 1988 Jun; 29(6):1130-5. PubMed ID: 2897436
[TBL] [Abstract][Full Text] [Related]
17. Contribution of different scintigraphic techniques to the management of medullary thyroid carcinoma.
Sandrock D; Blossey HC; Steinroeder M; Munz DL
Henry Ford Hosp Med J; 1989; 37(3-4):173-4. PubMed ID: 2576957
[TBL] [Abstract][Full Text] [Related]
18. The role of radiopharmaceuticals MIBG and (V) DMSA in the diagnosis of medullary thyroid carcinoma.
Verga U; Muratori F; Di Sacco G; Banfi F; Libroia A
Henry Ford Hosp Med J; 1989; 37(3-4):175-7. PubMed ID: 2576958
[TBL] [Abstract][Full Text] [Related]
19. Localization of metastases from medullary thyroid carcinoma using different methods.
Cabezas RC; Berna L; Estorch M; Carrio I; Garcia-Ameijeiras A
Henry Ford Hosp Med J; 1989; 37(3-4):169-72. PubMed ID: 2639132
[TBL] [Abstract][Full Text] [Related]
20. Metastatic medullary thyroid cancer: localization with iodine-131 metaiodobenzylguanidine.
Sone T; Fukunaga M; Otsuka N; Morita R; Muranaka A; Yanagimoto S; Tomomitsu T; Nakayama H; Harada T
J Nucl Med; 1985 Jun; 26(6):604-8. PubMed ID: 3158726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]